Policy Statements

The overall goal of hepatitis C elimination for PWID should be improved quality of life and enhanced access to high-quality, non-judgmental healthcare and prevention services, resulting in reductions in morbidity and mortality broadly. More

The Global Commission on Drug Policy releases a call-to-action report ’Beyond Punishment: From Criminal Justice Responses to Drug Policy Reform’. More

By addressing the hepatitis crisis, Pakistan can become a model for other nations in South Asia and beyond. Its large-scale elimination efforts, if successful, could inspire global confidence in the feasibility of achieving the WHO’s 2030 targets. More

To mark the Global Day of Action, 26 June, of the Support. Don’t Punish campaign, Amnesty International releases a policy paper to contribute to the advancement of drug policies that better uphold human rights. More

For a drug policy that makes Europe safer, healthier, and more just! A Manifesto, initiated by C-EHRN, lays down a vision for a pragmatic, innovative, and human rights-centred European drug policy. More

The decriminalisation of drug use and related activities is a policy option that is widely supported by the United Nations as a core component of a human rights- and health-based approach towards people who use drugs. More

UNAIDS welcomes the adoption of a key resolution at the 67th session of the United Nations Commission on Narcotic Drugs, recognizing harm reduction for the first time as an important part of an effective public health response. More

ACHIEVE issues a call to action outlining actions different actors (Member States, Stakeholders, European Commission and European Parliament) can take to eliminate viral hepatitis B and C in the European Union/European Economic Area. More

The dire need is to make hepatitis elimination a national priority with a strategic shift in governance and policy and ensuring the intelligent expenditure of resources. More

The statement calls for an end to the war on drugs, and for equal access to harm reduction and hepatitis prevention services, regardless of location or drug use status. More